Streetbeat News

Products Services

TIGR

UP Fintech Holding Limited (NASDAQ:TIGR) shares are rising due to China's recent stimulus measures, which include lower interest rates and increased liquidity. These measures are expected to benefit Chinese stocks, including Up Fintech, an online brokerage firm. The stock has surged nearly 100% in the past five sessions.

Portfolio Pulse from Erica Kollmann

October 02, 2024 | 3:20 pm

EWI

MSFT

Microsoft plans to invest €4.3 billion in Italy to enhance its AI infrastructure and cloud capacity. This move is part of Microsoft's strategy to expand its technological footprint in Europe.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 3:18 pm

LULU

NKE

Lululemon Athletica's shares dipped 0.9% following Nike's weaker-than-expected revenue report, raising concerns about the athletic apparel market. Nike's revenue decline highlights potential challenges for Lululemon, which may face headwinds due to softening consumer demand and macroeconomic pressures.

Portfolio Pulse from Henry Khederian

October 02, 2024 | 3:18 pm

META

Meta is launching a new Facebook Content Monetization Beta program that combines in-stream ads, ads on reels, and performance bonuses into a single monetization system. Open enrollment for this program will not be available until 2025.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 3:17 pm

FL

NKE

Foot Locker's stock is down 3.82% due to Nike's revenue miss, which impacts Foot Locker as a major retailer of Nike products. Nike's shift towards direct-to-consumer sales and declining performance in key markets like North America pose challenges for Foot Locker.

Portfolio Pulse from Henry Khederian

October 02, 2024 | 3:17 pm

KZIA

Kazia Therapeutics shares rose following the presentation of positive Phase I study data on paxalisib combined with radiation therapy for treating certain brain metastases at a major oncology conference.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 3:15 pm

GILD

RDY

Dr. Reddy's Laboratories has signed a voluntary licensing agreement with Gilead Sciences to manufacture and commercialize Lenacapavir in India and other countries. This agreement could expand Gilead's market reach and enhance Dr. Reddy's product offerings.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 3:10 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides a detailed analysis of key price levels for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. Traders are advised to monitor these stocks for potential breakouts or reversals, with specific bullish and bearish targets outlined for each. The memo also highlights the impact of upcoming economic data releases and Federal Reserve speeches on market volatility.

Portfolio Pulse from RIPS

October 02, 2024 | 3:10 pm

IYG

JPM

XLF

J.P. Morgan Asset Management is expanding its Canadian business by launching two active ETFs on the Toronto Stock Exchange, targeting income-focused investors. This move is part of a broader strategy to grow its presence in Canada, including plans to add up to 20 jobs. J.P. Morgan shares saw a slight increase following the announcement.

Portfolio Pulse from Lekha Gupta

October 02, 2024 | 3:07 pm

JNJ

PFE

Johnson & Johnson's Erleada shows a significant survival benefit over Pfizer's Xtandi in prostate cancer patients, according to a large study. J&J also plans a $2 billion investment in a new biologics facility.

Portfolio Pulse from Vandana Singh

October 02, 2024 | 3:00 pm